CTGF expression is indicative of better survival rates in patients with medulloblastoma (2020)
Cruzeiro, Gustavo Alencastro Veiga 
; Lira, Régia Caroline Peixoto ; Magalhães, Taciani de Almeida ; Scrideli, Carlos Alberto ; Valera, Elvis Terci ; Baumgartner, Martin; Tone, Luiz Gonzaga
Source: Cancer Gene Therapy. Unidade: FMRP
Subjects: MEDULOBLASTOMA, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRUZEIRO, Gustavo Alencastro Veiga et al. CTGF expression is indicative of better survival rates in patients with medulloblastoma. Cancer Gene Therapy, v. 27, n. 5, p. 378-382, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41417-019-0100-3. Acesso em: 31 out. 2024.APA
Cruzeiro, G. A. V., Lira, R. C. P., Magalhães, T. de A., Scrideli, C. A., Valera, E. T., Baumgartner, M., & Tone, L. G. (2020). CTGF expression is indicative of better survival rates in patients with medulloblastoma. Cancer Gene Therapy, 27( 5), 378-382. doi:10.1038/s41417-019-0100-3NLM
Cruzeiro GAV, Lira RCP, Magalhães T de A, Scrideli CA, Valera ET, Baumgartner M, Tone LG. CTGF expression is indicative of better survival rates in patients with medulloblastoma [Internet]. Cancer Gene Therapy. 2020 ; 27( 5): 378-382.[citado 2024 out. 31 ] Available from: https://doi.org/10.1038/s41417-019-0100-3Vancouver
Cruzeiro GAV, Lira RCP, Magalhães T de A, Scrideli CA, Valera ET, Baumgartner M, Tone LG. CTGF expression is indicative of better survival rates in patients with medulloblastoma [Internet]. Cancer Gene Therapy. 2020 ; 27( 5): 378-382.[citado 2024 out. 31 ] Available from: https://doi.org/10.1038/s41417-019-0100-3
